The Pharma Data

DECEMBER 11, 2020

And even when Black people with AML have the same access to treatment as white patients, their survival is shorter — something genetic differences might explain. Chancellor Donald, assistant professor of medicine, hematology and medical oncology at Tulane University School of Medicine in New Orleans, who led the briefing.

Genetics 52

Genetics Clinical Trials Clinical Trials Genetic Analysis 52

pharmaphorum

NOVEMBER 16, 2022

Crucial research for unmet needs and people’s future sight. The risk profile of developing AMD has been studied for years,” he said, “and more than 50% of a given individual’s risk profile is dependent on their genetics. That’s why there’s a lot of interest around this particular molecule and around this development programme.”.

Genetics 100

Genetics Trials Clinical Trials Clinical Trials 100

Drug Discovery World

MARCH 2, 2023

Going through the timeline of advances in this area, he initially focused on leukaemia as a success story in stem cell cancer treatment, and how researchers realised T cells from stem cell donors were eliminating residual cancer but also brought the risk of graft versus host disease (GvHD).

Trials 52

Trials Development Genetic Analysis Drugs 52

Drug Discovery World

FEBRUARY 28, 2023

As we turn our focus to new potential applications and disease areas for the platform, scientists and companies must consider the potential life-saving impact on rare, inherited diseases, says Archana Gupta , PhD, staff scientist in genetic sciences at Thermo Fisher Scientific.

Genetics 52

Genetics Genetic Analysis Vaccination Vaccine 52

pharmaphorum

APRIL 5, 2022

Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think could be used to predict which combinations are likely to work in cancer patients within two days. The researchers are already planning a larger follow-up study which will test 15 drugs and look at 12,000 tumour cell proteins.

Protein 67

Protein Genetic Analysis Genome Genomics 67

XTalks

DECEMBER 1, 2020

Over the past several years, personalized medicine has led the charge in medical innovation, leading drug development efforts as well as furthering the research community’s understanding of human disease states. In 2019 alone, worldwide pharma revenues totaled $1.25 trillion, with oncologics accounting for $99.5 billion in 2019.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

Drug Discovery World

APRIL 21, 2023

Atrandi Biosciences’ novel technology platform enables researchers to gain insights into the biology of single cells, offering immediate applications in single-cell sequencing, drug and antibody discovery, functional metagenomics, microbial analysis, directed evolution, and synthetic biology. It will be led by Björn C.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

Drug Discovery World

JUNE 14, 2023

Blood and stem cell donors are often also willing to provide products for ethically approved research and development. Besides looking at donor characteristics, our platform, which we call Excellos 360TM, includes the assessment of metabolic and effector potential of cells, and genetic analysis.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52